Abstract
Methamphetamine (Meth) seeking progressively increases after withdrawal (incubation of Meth craving), but the transcriptional mechanisms that contribute to this incubation are unknown. Here we used RNA-sequencing to analyze transcriptional profiles associated with incubation of Meth craving in central amygdala (CeA) and orbitofrontal cortex (OFC), two brain areas previously implicated in relapse to drug seeking. We trained rats to self-administer either saline (control condition) or Meth (10 days; 9 h/day, 0.1 mg/kg/infusion). Next, we collected brain tissue from CeA and OFC on withdrawal day 2 (when Meth seeking is low and non-incubated) and on day 35 (when Meth seeking is high and incubated), for subsequent RNA-sequencing. In CeA, we identified 10-fold more differentially expressed genes (DEGs) on withdrawal day 35 than day 2. These genes were enriched for several biological processes, including protein ubiquitination and histone methylation. In OFC, we identified much fewer expression changes than in CeA, with more DEGs on withdrawal day 2 than on day 35. There was a significant overlap between upregulated genes on withdrawal day 2 and downregulated genes on withdrawal day 35 in OFC. Our analyses highlight the CeA as a key region of transcriptional regulation associated with incubation of Meth seeking. In contrast, transcriptional regulation in OFC may contribute to Meth seeking during early withdrawal. Overall, these findings provide a unique resource of gene expression data for future studies examining transcriptional mechanisms in CeA that mediate Meth seeking after prolonged withdrawal.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Morley KC, Cornish JL, Faingold A, Wood K, Haber PS. Pharmacotherapeutic agents in the treatment of methamphetamine dependence. Expert Opin Investig Drugs. 2017;26:563–78.
Brecht ML, Herbeck D. Time to relapse following treatment for methamphetamine use: a long-term perspective on patterns and predictors. Drug Alcohol Depend. 2014;139:18–25.
Pickens CL, Airavaara M, Theberge FR, Fanous S, Hope B, Shaham Y. Neurobiology of incubation of cocaine craving. Trends Neurosci. 2011;34:411–20.
Wang G, Shi J, Chen N, Xu L, Li J, Li P, et al. Effects of length of abstinence on decision-making and craving in methamphetamine abusers. PLoS ONE. 2013;8:e68791.
Li X, Rubio FJ, Zeric T, Bossert JM, Kambhampati S, Cates HM, et al. Incubation of methamphetamine craving is associated with selective increases in expression of Bdnf and trkb, glutamate receptors, and epigenetic enzymes in cue-activated fos-expressing dorsal striatal neurons. J Neurosci. 201535:8232–44.
Li X, Carreria MB, Witonsky KR, Zeric T, Lofaro OM, Bossert JM, et al. Role of Dorsal Striatum Histone Deacetylase 5 in Incubation of Methamphetamine Craving. Biol Psychiatry. 2017 https://doi.org/10.1016/j.biopsych.2017.12.008
Li X, Witonsky KR, Lofaro OM, Surjono F, Zhang J, Bossert JM, et al. Role of anterior intralaminar nuclei of thalamus projections to dorsomedial striatum in incubation of methamphetamine craving. J Neurosci. 2018;38:2270–82.
Scheyer AF, Loweth JA, Christian DT, Uejima J, Rabei R, Le T, et al. AMPA receptor plasticity in accumbens core contributes to incubation of methamphetamine craving. Biol Psychiatry. 2016;80:661–70.
Robison AJ, Nestler EJ. Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci. 2011;12:623–37.
Li X, Zeric T, Kambhampati S, Bossert JM, Shaham Y. The central amygdala nucleus is critical for incubation of methamphetamine craving. Neuropsychopharmacology. 2015;40:1297–306.
Lu L, Hope BT, Dempsey J, Liu SY, Bossert JM, Shaham Y. Central amygdala ERK signaling pathway is critical to incubation of cocaine craving. Nat Neurosci. 2005;8:212–9.
Lu L, Uejima JL, Gray SM, Bossert JM, Shaham Y. Systemic and central amygdala injections of the mGluR(2/3) agonist LY379268 attenuate the expression of incubation of cocaine craving. Biol Psychiatry. 2007;61:591–8.
Li YQ, Li FQ, Wang XY, Wu P, Zhao M, Xu CM, et al. Central amygdala extracellular signal-regulated kinase signaling pathway is critical to incubation of opiate craving. J Neurosci. 2008;28:13248–57.
Funk D, Coen K, Tamadon S, Hope BT, Shaham Y, Le AD. Role of central amygdala neuronal ensembles in incubation of nicotine craving. J Neurosci. 2016;36:8612–23.
Uejima JL, Bossert JM, Poles GC, Lu L. Systemic and central amygdala injections of the mGluR2/3 agonist LY379268 attenuate the expression of incubation of sucrose craving in rats. Behav Brain Res. 2007;181:292–6.
Fuchs RA, Evans KA, Parker MP, See RE. Differential involvement of orbitofrontal cortex subregions in conditioned cue-induced and cocaine-primed reinstatement of cocaine seeking in rats. J Neurosci. 2004;24:6600–10.
Fanous S, Goldart EM, Theberge FR, Bossert JM, Shaham Y, Hope BT. Role of orbitofrontal cortex neuronal ensembles in the expression of incubation of heroin craving. J Neurosci. 2012;32:11600–9.
Lucantonio F, Stalnaker TA, Shaham Y, Niv Y, Schoenbaum G. The impact of orbitofrontal dysfunction on cocaine addiction. Nat Neurosci. 2012;15:358–66.
Schoenbaum G, Shaham Y. The role of orbitofrontal cortex in drug addiction: a review of preclinical studies. Biol Psychiatry. 2008;63:256–62.
Moeller SJ,Okita K,Robertson CL,Ballard ME,Konova AB,Goldstein RZ, et al. Low striatal dopamine D2-type receptor availability is linked to simulated drug choice in methamphetamine users. Neuropsychopharmacology. 2018;43:751–60.
Vollm BA, de Araujo IE, Cowen PJ, Rolls ET, Kringelbach ML, Smith KA, et al. Methamphetamine activates reward circuitry in drug naive human subjects. Neuropsychopharmacology. 2004;29:1715–22.
Goldstein RZ, Volkow ND, Chang L, Wang GJ, Fowler JS, Depue RA, et al. The orbitofrontal cortex in methamphetamine addiction: involvement in fear. Neuroreport. 2002;13:2253–7.
Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics. 2009;25:1105–11.
Purushothaman I, Shen L (2016). SPEctRA: A scalable pipeline for RNA-seq analysis. Github Repository Zenodo https://doi.org/10.5281/zenodo.60547. Last Accessed October 15, 2015.
Law CW, Chen Y, Shi W, Smyth GK. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15:R29.
Shen L (2013). GeneOverlap: Test and visualize gene overlaps. R package version 1.12.0. https://shenlab-sinaigithubio/shenlab-sinai/. Last Accessed May 8, 2018.
Mi H, Huang X, Muruganujan A, Tang H, Mills C, Kang D, et al. PANTHER version 11: expanded annotation data from Gene Ontology and Reactome pathways, and data analysis tool enhancements. Nucleic Acids Res. 2017;45(D1):D183–9.
Volkow ND, Fowler JS, Wang GJ, Hitzemann R, Logan J, Schlyer DJ, et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse. 1993;14:169–77.
Volkow ND, Fowler JS, Wolf AP, Hitzemann R, Dewey S, Bendriem B, et al. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry. 1991;148:621–6.
Kim SJ, Lyoo IK, Hwang J, Sung YH, Lee HY, Lee DS, et al. Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacology. 2005;30:1383–91.
London ED, Kohno M, Morales AM, Ballard ME. Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging. Brain Res. 2015;1628(Pt A):174–85.
London ED, Simon SL, Berman SM, Mandelkern MA, Lichtman AM, Bramen J, et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry. 2004;61:73–84.
Volkow ND, Chang L, Wang GJ, Fowler JS, Ding YS, Sedler M, et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry. 2001;158:2015–21.
Hegde AN. The ubiquitin-proteasome pathway and synaptic plasticity. Learn Mem. 2010;17:314–27.
Jarome TJ, Helmstetter FJ. Protein degradation and protein synthesis in long-term memory formation. Front Mol Neurosci. 2014;7:61.
Patrick GN. Synapse formation and plasticity: recent insights from the perspective of the ubiquitin proteasome system. Curr Opin Neurobiol. 2006;16:90–4.
Ren ZY, Liu MM, Xue YX, Ding ZB, Xue LF, Zhai SD, et al. A critical role for protein degradation in the nucleus accumbens core in cocaine reward memory. Neuropsychopharmacology. 2013;38:778–90.
Werner CT, Milovanovic M, Christian DT, Loweth JA, Wolf ME. Response of the ubiquitin-proteasome system to memory retrieval after extended-access cocaine or saline self-administration. Neuropsychopharmacology. 2015;40:3006–14.
Massaly N, Dahan L, Baudonnat M, Hovnanian C, Rekik K, Solinas M, et al. Involvement of protein degradation by the ubiquitin proteasome system in opiate addictive behaviors. Neuropsychopharmacology. 2013;38:596–604.
Komander D. The emerging complexity of protein ubiquitination. Biochem Soc Trans. 2009;37(Pt 5):937–53.
Jiao DL, Chen Y, Liu Y, Ju YY, Long JD, Du J, et al. SYVN1, an ERAD E3 ubiquitin ligase, is involved in GABAAalpha1 degradation associated with methamphetamine-induced conditioned place preference. Front Mol Neurosci. 2017;10:313.
Caffino L, Giannotti G, Malpighi C, Racagni G, Filip M, Fumagalli F. Long-term abstinence from developmental cocaine exposure alters Arc/Arg3.1 modulation in the rat medial prefrontal cortex. Neurotox Res. 2014;26:299–306.
Yan Y, Jiang W, Liu L, Wang X, Ding C, Tian Z, et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell. 2015;160:62–73.
Venniro M, Caprioli D, Zhang M, Whitaker LR, Zhang S, Warren BL, et al. The anterior insular cortex > central amygdala glutamatergic pathway is critical to relapse after contingency management. Neuron. 2017;96:414–27.
Kumari P, Srinivasan B, Banerjee S. Modulation of hippocampal synapse maturation by activity-regulated E3 ligase via non-canonical pathway. Neuroscience. 2017;364:226–41.
Dong Y, Taylor JR, Wolf ME, Shaham Y. Circuit and synaptic plasticity mechanisms of drug relapse. J Neurosci. 2017;37:10867–76.
Godino A, Jayanthi S, Cadet JL. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents. Epigenetics. 2015;10:574–80.
Aguilar-Valles A, Vaissiere T, Griggs EM, Mikaelsson MA, Takacs IF, Young EJ, et al. Methamphetamine-associated memory is regulated by a writer and an eraser of permissive histone methylation. Biol Psychiatry. 2014;76:57–65.
Acknowledgements
Funding and Disclosure:
This research was supported by intramural (YS) and extramural (EJN, P01DA008227) funds of NIDA, NIH. The authors declare that they do not have any conflicts of interest (financial or otherwise) related to the data presented in this manuscript.
Author contributions
HMC, XL, YS, and EJN designed experiments. HMC, XL, and PJK carried out experiments. HMC, XL, IP, and LS analyzed the data. HMC, XL, YS, and EJN wrote the manuscript.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cates, H.M., Li, X., Purushothaman, I. et al. Genome-wide transcriptional profiling of central amygdala and orbitofrontal cortex during incubation of methamphetamine craving. Neuropsychopharmacol 43, 2426–2434 (2018). https://doi.org/10.1038/s41386-018-0158-x
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/s41386-018-0158-x
This article is cited by
-
Methamphetamine-induced region-specific transcriptomic and epigenetic changes in the brain of male rats
Communications Biology (2023)
-
Cocaine induces paradigm-specific changes to the transcriptome within the ventral tegmental area
Neuropsychopharmacology (2021)
-
AMPA receptor and metabotropic glutamate receptor 1 adaptations in the nucleus accumbens core during incubation of methamphetamine craving
Neuropsychopharmacology (2019)
